{"filing":{"accession_number":"0001193125-26-266679","cik":"0000884624","ticker":"OFIX","company_name":"Orthofix Medical Inc.","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"ofix-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526266679/ofix-20260611.htm"},"events":[{"id":5332,"run_id":4670,"accession_number":"0001193125-26-266679","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Orthofix Medical Inc. held its Annual Meeting of Shareholders on June 10, 2026, with voting results disclosed on four matters: election of ten directors, advisory approval of executive compensation, ratification of Ernst \u0026 Young LLP as auditor, and approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan increasing available shares by 1,250,000.","company_name":"Orthofix Medical Inc.","ticker":"OFIX","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6076,"accession_number":"0001193125-26-266679","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure reports shareholder approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan, which increases shares available for issuance by 1,250,000 shares. This is a compensatory arrangement affecting named executive officers who participate in the SPP, and shareholder approval of such plan amendments falls squarely within exec_compensation. While filed under Item 5.02, the substance is a compensation plan amendment rather than an executive departure or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T11:02:18.624840+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6077,"accession_number":"0001193125-26-266679","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Orthofix Medical Inc.'s Annual Meeting of Shareholders held on June 10, 2026, including voting outcomes on four matters: election of ten directors, advisory approval of executive compensation, ratification of Ernst \u0026 Young LLP as auditor, and approval of an amendment to the stock purchase plan. The filing explicitly presents vote tallies (votes for, against, and abstentions) for each agenda item, which is the defining characteristic of shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T11:02:18.624840+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6076,"accession_number":"0001193125-26-266679","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure reports shareholder approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan, which increases shares available for issuance by 1,250,000 shares. This is a compensatory arrangement affecting named executive officers who participate in the SPP, and shareholder approval of such plan amendments falls squarely within exec_compensation. While filed under Item 5.02, the substance is a compensation plan amendment rather than an executive departure or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T11:02:18.624840+00:00","company_name":"Orthofix Medical Inc.","ticker":"OFIX","filing_date":"2026-06-11"},{"id":6077,"accession_number":"0001193125-26-266679","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Orthofix Medical Inc.'s Annual Meeting of Shareholders held on June 10, 2026, including voting outcomes on four matters: election of ten directors, advisory approval of executive compensation, ratification of Ernst \u0026 Young LLP as auditor, and approval of an amendment to the stock purchase plan. The filing explicitly presents vote tallies (votes for, against, and abstentions) for each agenda item, which is the defining characteristic of shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T11:02:18.624840+00:00","company_name":"Orthofix Medical Inc.","ticker":"OFIX","filing_date":"2026-06-11"}]}